BARCLAYS PLC - PREVAIL THERAPEUTICS INC ownership

PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 68 filers reported holding PREVAIL THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$110,000
-65.8%
4,778
-84.9%
0.00%
Q3 2020$322,000
+26.3%
31,625
+84.6%
0.00%
Q2 2020$255,000
+110.7%
17,132
+72.8%
0.00%
Q1 2020$121,000
+1.7%
9,916
+31.1%
0.00%
Q4 2019$119,000
+153.2%
7,564
+98.9%
0.00%
Q3 2019$47,0003,8030.00%
Other shareholders
PREVAIL THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,248,306$27,407,0002.86%
Orbimed Advisors 13,822,463$168,496,0002.83%
Omega Fund Management, LLC 272,807$3,326,0001.38%
RA Capital Management 3,240,534$39,502,0001.25%
Boxer Capital, LLC 1,123,105$13,691,0000.93%
BVF INC/IL 431,483$5,260,0000.49%
DAFNA Capital Management LLC 75,000$914,0000.38%
QVT Financial LP 133,690$1,630,0000.38%
Woodline Partners LP 251,532$3,066,0000.22%
Artal Group S.A. 200,000$2,438,0000.10%
View complete list of PREVAIL THERAPEUTICS INC shareholders